| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A16AX17 |
| UNII: | 2P6O7CFW5K |
| InChI Key | PJHKBYALYHRYSK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H44O6 |
| Molecular Weight | 428.61 |
| AlogP | 5.9 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 20.0 |
| Polar Surface Area | 78.9 |
| Molecular species | None |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 30.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Supplement | FDA |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ataxia Telangiectasia | 2 | D001260 | ClinicalTrials |
| Rett Syndrome | 2 | D015518 | ClinicalTrials |
| Glycogen Storage Disease | 2 | D006008 | ClinicalTrials |
| Huntington Disease | 2 | D006816 | ClinicalTrials |
| Hemiplegia | 2 | D006429 | ClinicalTrials |
| Glycogen Storage Disease Type VII | 2 | D006014 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 1 | D000690 | ClinicalTrials |
| Migraine Disorders | 0 | D008881 | ClinicalTrials |
| Glycogen Storage Disease Type I | 0 | D005953 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 620-67-7 |
| ChEMBL | CHEMBL4297585 |
| DrugBank | DB11677 |
| EPA CompTox | DTXSID40862306 |
| FDA SRS | 2P6O7CFW5K |
| PubChem | 69286 |
| SureChEMBL | SCHEMBL525618 |
| ZINC | ZINC000004521897 |